Avelumab Alone or in Combination With Chemotherapy Versus Chemotherapy Alone in Platinum-Resistant or Platinum-Refractory Ovarian Cancer (JAVELIN Ovarian 200): An Open-Label, Three-Arm, Randomised, Phase 3 Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Avelumab Alone or in Combination With Chemotherapy Versus Chemotherapy Alone in Platinum-Resistant or Platinum-Refractory Ovarian Cancer (JAVELIN Ovarian 200): An Open-Label, Three-Arm, Randomised, Phase 3 Study

Published:2021-11 Issue:11 Volume:76 Page:673-675
ISSN:1533-9866
Container-title:Obstetrical & Gynecological Survey
language:en
Short-container-title:

Author:

Pujade-Lauraine Eric,Fujiwara Keiichi,Ledermann Jonathan A.,Oza Amit M.,Kristeleit Rebecca,Ray-Coquard Isabelle-Laure,Richardson Gary E.,Sessa Cristiana,Yonemori Kan,Banerjee Susana,Leary Alexandra,Tinker Anna V.,Jung Kyung Hae,Madry Radoslaw,Park Sang-Yoon,Anderson Charles K.,Zohren Fabian,Stewart Ross A.,Wei Caimiao,Dychter Samuel S.,Monk Bradley J.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Obstetrics and Gynecology,General Medicine

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human 3D Ovarian Cancer Models Reveal Malignant Cell–Intrinsic and –Extrinsic Factors That Influence CAR T-cell Activity;Cancer Research;2024-05-31

2. The Poor Prognosis of Acquired Secondary Platinum Resistance in Ovarian Cancer Patients;Cancers;2024-02-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP